Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Phoenix Biotech Aquisition Corporation | PBAX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.85 | 5.85 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 4.12 - 12.80 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 5.85 | USD |
Phoenix Biotech Aquisition Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
36.54M | 6.25M | - | 0 | -2.54M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Phoenix Biotech Aquisition News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PBAX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 4.97 | 6.3999 | 4.12 | 6.17 | 22,632 | 0.88 | 17.71% |
6 Months | 10.95 | 12.80 | 4.12 | 8.54 | 7,422 | -5.10 | -46.58% |
1 Year | 10.82 | 12.80 | 4.12 | 9.62 | 5,666 | -4.97 | -45.93% |
3 Years | 10.14 | 12.80 | 4.12 | 10.03 | 29,603 | -4.29 | -42.31% |
5 Years | 10.14 | 12.80 | 4.12 | 10.03 | 29,603 | -4.29 | -42.31% |
Phoenix Biotech Aquisition Description
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe. |